Mechanism Comparison
Ipamorelin is a hexapeptide ghrelin receptor agonist (GHRP) with selectivity for GH secretion. Unlike GHRP-2 or GHRP-6, ipamorelin produces minimal effect on cortisol or prolactin, making it the cleanest GHRP tool for research isolating GH-specific effects. Ipamorelin is available from Lone Star Peptide Co. at ≥99% HPLC purity. Half-life: ~2 hours.
CJC-1295 (with DAC) is a GHRH analog with a drug affinity complex (DAC) that extends half-life to ~8 days. CJC-1295 stimulates pituitary somatotrophs to increase GH release, creating sustained elevation of baseline GH. CJC-1295 is supplied by Lone Star Peptide Co. as lyophilized powder at ≥99% HPLC purity.
Molecular Comparison Table
| Property | Ipamorelin | CJC-1295 |
|---|---|---|
| Receptor Target | Ghrelin receptor (GHSR-1a) | GHRH receptor (pituitary) |
| Amino Acids | 6-amino acid hexapeptide | 30-amino acid GHRH analog |
| Half-Life | ~2 hours | ~8 days (with DAC) |
| Mechanism Class | Pulsatile GH releaser | Sustained GH elevator |
| Selectivity | GH-selective (minimal cortisol/prolactin) | GH-specific via GHRH |
| Research Use | Acute GH pulse studies | Sustained GH elevation models |
Why Ipamorelin is Preferred Over GHRP-6
Ipamorelin's selectivity for GH secretion without significant cortisol or prolactin elevation is the primary reason researchers favor it over GHRP-2 and GHRP-6. GHRP-6 causes marked cortisol stimulation and appetite stimulation confounds; ipamorelin avoids these off-target effects while maintaining robust GH release. This selectivity makes ipamorelin the gold standard GHRP for research isolating GH-specific biology.
The CJC-1295/Ipamorelin Combination Research Rationale
When used together, ipamorelin and CJC-1295 create a dual-mechanism GH secretion model:
- Ipamorelin: Acute, pulsatile GH release via ghrelin receptor activation
- CJC-1295: Sustained baseline GH elevation via GHRH pathway
- Combined: Synergistic GH output that models both pulsatile and tonic secretion patterns
This combination is physiologically relevant because native GH secretion is biphasic — pulsatile bursts combined with sustained basal elevation. Lone Star Peptide Co. offers a pre-formulated CJC-1295/Ipamorelin Blend for researchers who want both mechanisms in a single vial.
Ipamorelin's GHSR-1a selectivity is critical for clean GH research. In whole-animal or cell-based models where cortisol or prolactin confounds would complicate interpretation, ipamorelin is the preferred GHRP. If studying ghrelin receptor's non-GH effects, GHRP-6 may be appropriate, but for GH-specific biology, ipamorelin is superior.
Research Applications
Both compounds are used in distinct research contexts:
Ipamorelin Research:
- Muscle protein synthesis studies (GH mechanism)
- IGF-1 pathway research and GH responsiveness
- Bone metabolism and osteoblast function
- Metabolic rate and energy expenditure
- Ghrelin receptor selectivity studies
CJC-1295 Research:
- Sustained GH elevation models
- GHRH receptor biology and pituitary responsiveness
- Long-duration GH pathway studies
- IGF-1 cumulative exposure research
- Chronic GH elevation metabolic effects
Texas Research Context
Both ipamorelin and CJC-1295 are available from Lone Star Peptide Co. for Texas research institutions with same-day dispatch before 2 PM CST. The CJC-1295/Ipamorelin Blend is in stock for convenient combined-pathway research. All compounds are verified to ≥99% HPLC purity with full COA documentation available in our public COA library.
Frequently Asked Questions
FOR RESEARCH USE ONLY. All compounds referenced in this article are supplied exclusively for in vitro and laboratory research by qualified scientists. Not intended for human or animal consumption, therapeutic use, or clinical application. Lone Star Peptide Co. makes no therapeutic claims regarding any compound referenced herein.